Advances in Pharmacoepidemiology and Drug Safety

Rakesh K Srivastava

Rakesh K Srivastava, PhD
Executive Editor
Professor, Department of Pharmacology
University of Kansas, USA

Biography

Dr. Rakesh K. Srivastava completed his B.Sc. (1978-81), M.Sc. (1981-84) and from University of Allahabad. U.P, India. M.Sc (1987-90) from Memorial University of Newfoundland, St.John, Newfoundlaland Canada. Ph.D.(1994-94) from University of Guelph, Ontario,Canada. Postdoctoral Fellow (1994-96) National Cancer Institute, National Institutes of Health, Bethesda, MD,20892. He worked as a Research Associate (1996-99) National research Council, National Academy of sciences, Assistant Professor (1999-2005) in Department of Pharmaceutical science, University of Maryland, Baltimore, MD. Assistant Professor (2005-2008) Dept of Biochemistry, University of Texas, Health Science center at Tyler, TX Professor (2008-2009) Dept of Biochemistry, University of Texas, Health Science center at Tyler, TX Tyler Endowed Professor (2009-Present)-Dept of Pharmacology, Toxicology and Therapeutics,and Medicine, University of Kansas Medical center, Kansas City, Kansas. Kansas Bioscience Authority Eminent Scholar, 2010.

Research Interest

Cancer therapy, Prevention, Stem cell, Drug discovery and development, Cell signaling, Apoptosis.